|John Rogers (Joint Keynote)
Title: Soft Electronic and Microfluidic Systems for the Skin
Abstract: Recent advances in materials, mechanics and manufacturing establish the foundations for high performance classes of electronics and other microsystems technologies that have physical properties precisely matched those of the human epidermis. The resulting devices can integrate with the skin in a physically imperceptible fashion, to provide continuous, clinical-quality information on physiological status. This talk summarizes the key ideas and presents specific examples in wireless monitoring for neonatal intensive care, and in capture, storage and biomarker analysis of sweat.
Bio: Professor John A. Rogers is the Louis Simpson and Kimberly Querrey Professor of Materials Science and Engineering, Biomedical Engineering and Medicine, with affiliate appointments in Mechanical Engineering, Electrical and Computer Engineering and Chemistry, where he is also Director of the newly endowed Center for Bio-Integrated Electronics. He has published more than 650 papers, is a co-inventor on more than 100 patents and he has co-founded several successful technology companies. His research has been recognized by many awards, including a MacArthur Fellowship (2009), the Lemelson-MIT Prize (2011), and the Smithsonian Award for American Ingenuity in the Physical Sciences (2013) – and most recently the MRS Medal from the Materials Research Society (2018). He is a member of the National Academy of Engineering, the National Academy of Sciences, the National Academy of Inventors and the American Academy of Arts and Sciences.
|James L. Madara, MD
American Medical Association
Title: The Future of Healthcare and Implications for Digital Health
Abstract: Healthcare in the USA consumes 18% ($3.5 Trillion) of the national GDP. As this cost has increased over the last half century, simultaneously there has been a massive shift in disease burden from episodic/acute to chronic disease (chronic disease now accounts for >80% of the healthcare spend). Yet the structure of medical school curricula/ongoing learning, as well as the structure of the health care system overall have only modestly adapted to these striking changes in the type of disease the country faces. In parallel, the digital revolution, remote monitoring, telemedicine, and an astounding growth in health data are edging into healthcare, but our “system” remains fragmented and siloed with poor incorporation of clinical data organization, interoperability, and data liquidity. The AMA has approached these problems by: developing and piloting the medical school and educational networks of tomorrow, creating new connected approaches to chronic disease, and defining how one can turn this non-system into more of a authentic system. Doing this requires rethinking the use of digital environments and, in particular, creating advances in the organization and liquidity of clinical data. Accomplishing this required the AMA to launch an independently operating Silicon Valley innovation company (Health2047.com) which has successfully launched companies with efforts ranging from clinical data liquidity (Akiri.com) to “uberization” of the approach to chronic disease (First Mile Care.com); while, at AMA headquarters in Chicago, producing new approaches to clinical data organization (https://www.ama-assn.org/amaone/integrated-health-model-initiative-ihmi ), a digital network to connect entrepreneurs with physicians having like interests (https://innovationmatch.ama-assn.org) , and a digital medicine advisory group (https://www.ama-assn.org/practice-management/digital/digital-medicine-payment-advisory-group) to provide a more disciplined approach to the digital space in medicine.
Bio: James L. Madara, MD, is CEO of the American Medical Association. His career began with 20+ years at Harvard where he received clinical and research training, served as a tenured professor of pathology and was director of the NIH-sponsored Harvard Digestive Disease Center. After five years as chair of pathology (Emory), Madara served as the Thompson Distinguished Service Professor and dean of the University of Chicago Pritzker School of Medicine, and as CEO of the University of Chicago Hospitals. Along with his current position, Madara is chairman of Health2047 Inc. An independent C-corporation, Health2047 is a San Francisco-based design firm whose mission is to help advance the AMA’s goal of improving the health of the nation through innovative solutions.
|Elazer R. Edelman
Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, USA
Title: How Computational Modeling Drove Revolution in Cardiovascular Medicine
Abstract:(to be updated)
Bio: Elazer R. Edelman is Edward Poitras Professor Medical Engineering and Science MIT, Professor of Medicine Harvard Medical School, and Senior Attending Physician Brigham and Women's Hospital. He directs MIT’s Institute for Medical Engineering and Sciences dedicated to applying physical sciences to biologic processes and disease mechanisms, and home to graduate and medical doctoral degrees programs. His research interests meld medical and scientific training leveraging pathophysiologic insight to improve clinical decision-making and device design.
VP Diagnostics Information Solutions
Roche Diagnostics Corporation